Mission Statement, Vision, & Core Values (2026) of Beijing Tong Ren Tang Chinese Medicine Company Limited.

From its founding in 1669 and a legacy stretching over 350 years, Beijing Tong Ren Tang Chinese Medicine Company Limited has grown into a global ambassador for Traditional Chinese Medicine, operating more than 160 retail branches across 26 countries and regions from its headquarters in Hong Kong, guided by a mission of 'Cultivating Kind-heartedness and Benefiting Mankind and Preserving Health' that ties ethical practice to profit and community wellbeing; the company pairs a steadfast commitment to authentic, high-quality herbal medicines with a forward-looking vision to integrate ancient wisdom and modern science-investing in R&D, expanding to over 30 countries and more than 200 outlets worldwide as it pursues sustainability targets such as reducing its carbon footprint by 30% by 2025, while core values of integrity, innovation, customer focus, social responsibility and uncompromising quality steer its role in promoting Chinese medicine culture globally.

Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) - Intro

• Founded: 1669 - more than 350 years of continuous practice and reputation-building.
• Global footprint: operates over 160 retail branches across 26 countries and regions.
• Headquarters: Hong Kong - positioned as the group's international development and branding hub.
• Public listing: traded as 3613.HK on the Hong Kong Stock Exchange.

• Motto and quality commitment: "No compromise on cost and labour despite the complexity of processing herbal medicine. No compromise on quality and standard despite the scarcity of medicine ingredients."
• Strategic focus: integrate traditional prescriptions and herbal knowledge with modern R&D, production controls and international regulatory compliance.

• Preserve and transmit authentic TCM knowledge and practices.
• Provide safe, effective and ethically produced Chinese medicines and wellness solutions worldwide.
• Bridge traditional wisdom and modern science to enhance public health and preventive care.

• To be the global ambassador of Traditional Chinese Medicine-trusted, accessible and scientifically credible.
• To expand international access to TCM through retail presence, education and integrated healthcare collaborations.
• To foster innovation that modernises traditional formulas while maintaining provenance and therapeutic integrity.

• Authenticity - rigorous source control and faithful adherence to classical formulations.
• Quality-first - uncompromising standards from ingredient sourcing to finished product testing.
• Innovation - continuous R&D to validate, standardise and scale TCM solutions for modern markets.
• Responsibility - ethical stewardship of herbal resources and patient-centric service.
• Global stewardship - cultural promotion and compliant international expansion to share TCM benefits worldwide.

• Retail and service expansion: consolidating the >160-branch network and adding service-oriented wellness clinics internationally.
• R&D and standardisation: investing in modern extraction, quality assurance and clinical validation to meet global regulatory standards.
• Brand and culture: leveraging the 350+ year heritage to educate consumers and partners on TCM's history, safety and efficacy.
• Sustainable sourcing: implementing traceability and conservation measures for key herbal ingredients.

Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) - Overview

'Cultivating Kind-heartedness and Benefiting Mankind and Preserving Health' is both Tong Ren Tang's mission and its spirit. This mission underpins strategic decisions, product development, clinical services and global expansion, positioning Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) as a heritage-driven healthcare enterprise that links traditional Chinese medicine (TCM) with modern commercial practice.

The company is dedicated to improving and enhancing the health and life quality of people worldwide by combining classical formulations, modern R&D and regulated manufacturing. Tong Ren Tang explicitly ties commercial success to social responsibility - operating under the principle of performing good deeds along with making profits, and emphasizing benevolence and competence in treating patients.

• Mission-driven care: commitment to ethical practice in patient treatment and product integrity.
• Cultural stewardship: active promotion and protection of Chinese medicine culture domestically and abroad.
• Sustainable profit orientation: aligning profit-making with positive societal health outcomes.
• Global accessibility: expanding international footprint through pharmacies, franchising and cross-border e-commerce.

The mission manifests operationally in clinical governance, quality assurance, and public health outreach - ensuring that manufacturing, clinical prescriptions and retail services reflect both competence and compassion. This dual emphasis has supported steady commercial performance while safeguarding brand trust built over centuries.

The mission's ethical contours influence corporate governance, product portfolio and community engagement:

• Quality-first production: GMP-compliant manufacturing and batch traceability to ensure safety and efficacy.
• Clinical standards: emphasis on trained practitioners, standardized prescriptions and patient-centered care.
• Research & development: investment in TCM modernization and clinical studies to validate formulations.
• Education & culture: public education campaigns and cross-border cultural initiatives to raise TCM awareness.

Upholding benevolence and competence also shapes Tong Ren Tang's internationalization strategy - balancing brand stewardship with scalable retail and digital channels to grow non‑China revenue. Operational metrics reflect this: growing retail footprint, improving margins from product mix optimization, and rising R&D spend aimed at regulatory approvals and evidence-based product claims.

For an investor-focused perspective on ownership, trading and who's buying and why, see: Exploring Beijing Tong Ren Tang Chinese Medicine Company Limited Investor Profile: Who's Buying and Why?

Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) - Mission Statement

• Preserve and standardize classic TCM formulas while ensuring modern quality control and regulatory compliance.
• Expand evidence-based research to validate efficacy and safety through clinical trials and modern pharmacology.
• Scale integrated healthcare services - from raw herb sourcing and manufacturing to retail, clinical services and digital health platforms.
• Promote sustainable sourcing, manufacturing and operations to lower environmental impact across the value chain.

• R&D-led transformation: continuous investment in clinical research, product development and digital healthcare integration.
• Global leadership: accelerate international presence while maintaining product authenticity and regulatory compliance in target markets.
• Sustainable operations: reduce carbon footprint and resource intensity across production, logistics and retail.

• Innovative R&D pipelines combining TCM theory with modern biotech methods - clinical trials, standardization and new delivery systems.
• International expansion via joint ventures, export partnerships and regulated-market approvals to ensure compliant entry into developed healthcare systems.
• Sustainability programs targeting energy efficiency in manufacturing, green packaging, supplier audits and logistics optimization to meet the 30% CO2 reduction target.
• Omnichannel retail strategy integrating 200+ physical outlets with e-commerce and telemedicine services to broaden access and improve continuity of care.

Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) - Vision Statement

• Integrity - Transparent governance, traceable supply chains, and strict compliance: the company reports full traceability for active herbal ingredients across >95% of major SKUs and maintains a long-standing zero-tolerance policy for adulteration.
• Innovation - Sustained investment in R&D and modern manufacturing: recent capital allocation targets R&D at roughly 2-4% of annual revenue, funding clinical studies, quality control laboratories, and GMP upgrades.
• Customer focus - Retail and digital expansion to meet diverse needs: omnichannel sales growth has driven repeat-customer rates above industry averages through personalized formulations and e-health services.
• Social responsibility - Community health programs and sustainability: initiatives include public TCM clinics, eldercare partnerships, and supplier sustainability audits covering key herb sourcing regions.
• Quality commitment - Rigorous quality assurance from raw herb to finished product: standardized testing, third-party verification for heavy metals/pesticides, and preservation of traditional decoction methods where clinically relevant.

• Investment allocation - Priority to R&D facilities and digital health platforms to translate innovation into validated clinical products, reflected in multi-year capex plans.
• Supply-chain governance - Supplier audits, GPS/QR traceability for key herbs, and efforts to vertically integrate cultivation for high-risk raw materials to secure quality and reduce volatility.
• Customer-centric product design - Expanded SKUs for geriatrics, chronic disease management, and wellness; personalized decoction services and subscription programs to increase LTV.
• ESG and community impact - Measurable targets for reduced energy/water use at manufacturing sites and outreach metrics for free clinics and public education campaigns.

• Brand moat - Deep heritage and strict quality controls support pricing power and margin resilience.
• Growth drivers - R&D-backed product innovation, international expansion, and digital channels are key catalysts for incremental revenue.
• Risk framework - Agricultural supply volatility, regulatory scrutiny, and competition from modern pharmaceuticals are managed via vertical integration and compliance investments.